Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: olanzapine ×Clear filters

Showing 1–4 of 4 results

Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia — Neuropsychopharmacology Reports (2025)• Drug: olanzapinePMID
Comparative effects of 18 antipsychotics on metabolic function in schizophrenia: systematic review and network meta-analysis. — The Lancet Psychiatry (2020)• Drug: olanzapineOpen accessDOI PMID PMCID
Metabolic effects of olanzapine: systematic review — Systematic review (2019)• Drug: olanzapine
Olanzapine/fluoxetine for bipolar depression: randomized trials — RCTs (2016)• Drug: olanzapine

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses